Key facts
- It has raised $26.8M; the latest was Later Stage VC ($9.8M) in Apr 2024.
- Notable investors include Capital Factory, United States Department of War, Tribe Capital, Innovation Works, Human Capital — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Apollo (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Apollo (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apollo (Therapeutic Devices)
Developer of a wearable device designed to improve the body's resilience to stress. The company offers a wearable touch therapy device that is worn on the user's ankle or wrist and provides silent, soothing vibrations to the wearer's nervous system, telling them they are safe and in control, enabling patients to have safe, non-invasive stress relief tools without the side effects of drugs.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2017
- Employees
- 17
- Website
- apolloneuro.com/
- Ownership
- Privately Held (backing)
Apollo (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apollo (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apollo (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.